Bank of America’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-545
| Closed | -$21K | – | 7667 |
|
|
2016
Q3 | $21K | Buy |
545
+28
| +5% | +$312 | ﹤0.01% | 6118 |
|
|
2016
Q2 | $6K | Sell |
517
-769
| -60% | -$7.16K | ﹤0.01% | 6653 |
|
|
2016
Q1 | $11K | Sell |
1,286
-62
| -5% | -$468 | ﹤0.01% | 6378 |
|
|
2015
Q4 | $14K | Buy |
1,348
+983
| +269% | +$10.2K | ﹤0.01% | 6579 |
|
|
2015
Q3 | $4K | Sell |
365
-71
| -16% | -$996 | ﹤0.01% | 6863 |
|
|
2015
Q2 | $8K | Buy |
436
+432
| +10,800% | +$6.32K | ﹤0.01% | 6686 |
|
|
2015
Q1 | $0 | Buy |
+4
| New | +$43 | ﹤0.01% | 7922 |
|
|
2014
Q4 | – | Sell |
-18
| Closed | – | – | 8222 |
|
|
2014
Q3 | $0 | Sell |
18
-704
| -98% | -$13.9K | ﹤0.01% | 8341 |
|
|
2014
Q2 | $44K | Buy |
722
+711
| +6,464% | +$43.2K | ﹤0.01% | 6749 |
|
|
2014
Q1 | $1K | Sell |
11
-109
| -91% | -$7.65K | ﹤0.01% | 7691 |
|
|
2013
Q4 | $5K | Sell |
120
-459
| -79% | -$21.5K | ﹤0.01% | 7485 |
|
|
2013
Q3 | $35K | Buy |
+579
| New | +$30.3K | ﹤0.01% | 6634 |
|
Bank of America's TBRA Position: Q4 2016 in Review
Bank of America sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 545 shares — an estimated $21K sold.
Bank of America first reported a position in TBRA in Q3 2013 and held it in 12 quarters. The position peaked at $44K in Q2 2014. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.
- Bank of America reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
- Bank of America sold 545 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $21K.
- Bank of America first reported a position in Tobira Therapeutics, Inc. Common Stock in Q3 2013 and held it in 12 quarters.
- Bank of America's Tobira Therapeutics, Inc. Common Stock position peaked at $44K in Q2 2014.
- 0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.
Based on Bank of America's 13F filing for Q4 2016, filed 14 Feb 2017.